https://www.selleckchem.com/pr....oducts/actinomycin-d
018. The probability of local tumor control after radiotherapy (RT) remains still miserably poor in pediatric rhabdomyosarcoma (RMS). Thus, understanding the molecular mechanisms responsible of tumor relapse is essential to identify personalized RT-based strategies. Contrary to what has been done so far, a correct characterization of cellular radioresistance should be performed comparing radioresistant and radiosensitive cells with the same isogenic background. Clinically relevant radioresistant (RR) embryonal (RD) and alveolar (R
Like
Comment
Share
